Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Short-Term Debt issuances (2020 - 2022)

Palisade Bio (PALI) has disclosed Short-Term Debt issuances for 3 consecutive years, with -$1.2 million as the latest value for Q4 2022.

  • On a quarterly basis, Short-Term Debt issuances changed N/A to -$1.2 million in Q4 2022 year-over-year; TTM through Dec 2022 was -$1.2 million, a N/A change, with the full-year FY2021 number at $1.2 million, up 229.82% from a year prior.
  • Short-Term Debt issuances was -$1.2 million for Q4 2022 at Palisade Bio, down from $1.2 million in the prior quarter.
  • In the past five years, Short-Term Debt issuances ranged from a high of $1.2 million in Q1 2021 to a low of -$1.2 million in Q4 2022.
  • A 3-year average of $33333.3 and a median of $100000.0 in 2020 define the central range for Short-Term Debt issuances.